QiuCRFuQSuiJ. Serum endothelial cell–specific molecule 1 (endocan) levels in patients with acute myocardial infarction and its clinical significance: a pilot study [published online May 25, 2016]. Angiology. doi:10.1177/0003319716651349.
2.
ZhangSMZuoLZhouQ. Expression and distribution of endocan in human tissues. Biotech Histochem. 2012;87(3):172–178.
3.
CoxLAvan EijkLTRamakersBP. Inflammation induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo. Shock. 2015;43(4):322–326.
4.
KundiHBalunACicekciogluH. Admission endocan level may be a useful predictor for in-hospital mortality and coronary severity index in patients with ST-segment elevation myocardial infarction. Angiology. 2017;68(1):46–51.
5.
ÇimenTEfeTHAkyelA. Human endothelial cell-specific molecule-1 (endocan) and coronary artery disease and microvascular angina. Angiology. 2016;67(9):846–853.
6.
ErtemAGEfeTHYaylaC. The association between serum procalcitonin levels and severity of coronary artery disease assessed by SYNTAX score in patients with acute coronary syndrome. Angiology. 2017;68(1):40–45.
